The 1-2 Punch of the Covid Jab - knockout in round 2
by Craig Paardekooper

Background
It has been reported from analysis of VAERS by Jessica Rose, that there is a significantly higher incidence ofmyocarditis following dose 2 of Pfizer BNT162b2 compared to dose 1. This applies to all age groups, but especially toyounger age groups. Dr Rose found that for 15 year-olds, incidence of myocarditis after dose 2 was 6 x that after
dose 1.

As you can see, for EVERY age groupbetween 14 and 60 the number ofmyocarditis cases after dose 2 alwaysexceeds the number of myocarditis
cases after dose 1.
A Report on Myocarditis Adverse
Events in the U.S. Vaccine Adverse
Events Reporting System (VAERS) inAssociation with COVID-19 Injectable
Biological Products (substack.com)

MethodI wanted to check this for myself, so I took all of the 2021 VAERS data for the USA as my data source. The database
was downloaded on the 15th August 2022.
The total number of adverse reaction reports for dose 1 and dose 2 were counted. (I used vlookup to import thedoses column into the main table).
The number of cases where the symptoms included myocarditis was counted (I used vlookup to import the 5symptoms columns into the main table).
The number of cases of myocarditis per 100,000 reports was then calculated for each dose.
Results
Myocarditis
Dose 1 : 353809 records

Myocarditis cases : 259= 73 cases per 100,000 reports

Dose 2 : 189591 records

Myocarditis cases : 519= 273 cases per 100,000 reports

On average, the incidence of myocarditis after dose 2 is 3.74 x the incidence after dose 1.
Chest Pain
Dose 1 : 353809 records

Chest pain cases : 9264

= 2600 cases per 100,000 reports

Dose 2 : 189591 records

Chest pain cases : 6665

= 3500 cases per 100,000 reports

On average, the incidence of chest pain after dose 2 is 1.34 x the incidence after dose 1.

Looking at Different Age Groups

This graph shows the number of cases of myocarditis after dose 1 and after dose 2. It is already apparent that dose 2
is worse than dose 1, but the situation is worse yet, since fewer people have taken dose 2 compared to dose 1.
To put this problem into perspective, the number of records for dose 1 in VAERS was 353809, whilst the number ofrecords for dose 2 was 189591.
So I needed to take into account the population size for each age at dose 1, and the same for the population size foreach age at dose 2. I then obtained the number of cases of myocarditis per 100,000 reports for each age group.
I divided the number of myocarditis cases for each age by the total number of VAERS reports for each age , to obtainthe number of cases of myocarditis per 100,000 reports for each age.

Observations•••

The incidence of myocarditis is higher in younger age groups after both dose 1 and dose 2
The second dose produces a significantly higher incidence of myocarditis compared to the first dose (up to10 x)
The second dose is only more toxic than the first dose for younger age groups (below 40 years old). Why isthis??? The degree of toxicity rises to 3.7% of records for dose 2 compared to 0.4% of records for dose 1.

Additional Studies Confirm Link to Second Dose
Vigibase Study
A study using Vigibase (the WHO’s database of adverse event reports) found that the incidence of myocarditis was 5fold higher after dose 2 compared to after dose 1 for the age range 12-17 years-old.
See who.pdf (howbad.info)
MIT Study
A study my MIT found a 25% increase in emergency calls for cardiac arrests in 16-39 year olds in Israel – coinciding
with the vaccine roll-out in January to April 2021. This increase did not coincide with the incidences of COVID
infection which were decreasing during this period – but they did coincide with the increase in COVID vaccine
administration. The increase began simultaneously with the rollout of the first dose, and peaked with the rollout of
the second dose. See - Increased emergency cardiovascular events among under-40 population in Israel during
vaccine rollout and third COVID-19 wave | Scientific Reports (nature.com)

The same pattern occurred for acute coronary syndrome